Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & EquivalentsCommon EquityCurrent AssetsCurrent Deferred RevenueCurrent LeasesLiabilities and Shareholders EquityMinority InterestNon-Current AssetsNon-Current DebtNon-Current Deffered RevenueOperating LeasesOther Non-Current AssetsPayablesPrepaid AssetsProperty, Plant & Equipment (Net)Property, Plant & Equipment (Net)ReceivablesReceivables - NetRetained EarningsShareholder's EquityShares OutstandingShort term DebtTotal Current LiabilitiesTotal DebtTotal LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Rani Therapeutics Holdings (RANI) Other Non-Current Assets (2021 - 2026)

Rani Therapeutics Holdings' Other Non-Current Assets history spans 5 years, with the latest figure at $246000.0 for Q1 2026.

  • On a quarterly basis, Other Non-Current Assets changed 0.0% to $246000.0 in Q1 2026 year-over-year; TTM through Mar 2026 was $246000.0, a 0.0% change, with the full-year FY2025 number at $246000.0, changed 0.0% from a year prior.
  • Other Non-Current Assets came in at $246000.0 for Q1 2026, roughly flat from $246000.0 in the prior quarter.
  • The five-year high for Other Non-Current Assets was $293000.0 in Q2 2025, with the low at $245000.0 in Q3 2025.
  • Historically, Other Non-Current Assets has averaged $250600.0 across 4 years, with a median of $246000.0 in 2023.
  • Peak annual rise in Other Non-Current Assets hit 19.11% in 2025, while the deepest fall reached 0.41% in 2025.
  • Year by year, Other Non-Current Assets stood at $246000.0 in 2023, then changed by 0.0% to $246000.0 in 2024, then changed by 0.0% to $246000.0 in 2025, then changed by 0.0% to $246000.0 in 2026.
  • Business Quant data shows Other Non-Current Assets for RANI at $246000.0 in Q1 2026, $246000.0 in Q4 2025, and $245000.0 in Q3 2025.